A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation

被引:115
作者
Daniel, S
Arvelo, MB
Patel, VI
Longo, CR
Shrikhande, G
Shukri, T
Mahiou, J
Sun, DW
Mottley, C
Grey, ST
Ferran, C
机构
[1] Harvard Univ, Sch Med, Dept Surg & Med, Div Vasc Surg, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Immunol Res Ctr, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02215 USA
关键词
D O I
10.1182/blood-2003-02-0635
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A20 is a stress response gene in endothelial cells (ECs). A20 serves a dual cytoprotective function, protecting from tumor necrosis factor (TNF)-mediated apoptosis and inhibiting inflammation via blockade of the transcription factor nuclear factor-kappaB (NF-kappaB). In this study, we evaluated the molecular basis of the cytoprotective function of A20 in EC cultures and questioned whether its protective effect extends beyond TNF to other apoptotic and necrotic stimuli. Our data demonstrate that A20 targets the TNF apoptotic pathway by inhibiting proteolytic cleavage of apical caspases 8 and 2, executioner caspases 3 and 6, Bid cleavage, and release of cytochrome c, thus preserving mitochondrion integrity. A20 also protects from Fas/CD95 and significantly blunts natural killer cell-mediated EC apoptosis by inhibiting caspase 8 activation. In addition to protecting ECs from apoptotic stimuli, A20 safeguards ECs from complement-mediated necrosis. These data demonstrate, for the first time, that the cytoprotective effect of A20 in ECs is not limited to TNF-triggered apoptosis. Rather, A20 affords broad EC protective functions by effectively shutting down cell death pathways initiated by inflammatory and immune offenders. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:2376 / 2384
页数:9
相关论文
共 65 条
[1]  
Ahmad M, 1997, CANCER RES, V57, P615
[2]   A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis [J].
Arvelo, MB ;
Cooper, JT ;
Longo, C ;
Daniel, S ;
Grey, ST ;
Mahiou, J ;
Czismadia, E ;
Abu-Jawdeh, G ;
Ferran, C .
HEPATOLOGY, 2002, 35 (03) :535-543
[3]   Cytotoxic T lymphocyte-assisted suicide - Caspase 3 activation is primarily the result of the direct action of granzyme B [J].
Atkinson, EA ;
Barry, M ;
Darmon, AJ ;
Shostak, I ;
Turner, PC ;
Moyer, RW ;
Bleackley, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (33) :21261-21266
[4]   Protective genes expressed in endothelial cells: a regulatory response to injury [J].
Bach, FH ;
Hancock, WW ;
Ferran, C .
IMMUNOLOGY TODAY, 1997, 18 (10) :483-486
[5]   Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving bid [J].
Barry, M ;
Heibein, JA ;
Pinkoski, MJ ;
Lee, SF ;
Moyer, RW ;
Green, DR ;
Bleackley, RC .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (11) :3781-3794
[6]  
Berard R, 1999, J IMMUNOL, V163, P4655
[7]   A20 and A20-binding proteins as cellular inhibitors of nuclear factor-κB-dependent gene expression and apoptosis [J].
Beyaert, R ;
Heyninck, K ;
Van Huffel, S .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) :1143-1151
[8]   Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death [J].
Boldin, MP ;
Goncharov, TM ;
Goltsev, YV ;
Wallach, D .
CELL, 1996, 85 (06) :803-815
[9]   FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS [J].
CHINNAIYAN, AM ;
OROURKE, K ;
TEWARI, M ;
DIXIT, VM .
CELL, 1995, 81 (04) :505-512
[10]   A20 blocks endothelial cell activation through a NF-kappa B-dependent mechanism [J].
Cooper, JT ;
Stroka, DM ;
Brostjan, C ;
Palmetshofer, A ;
Bach, FH ;
Ferran, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) :18068-18073